Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.36 |
| ▸ | CA4 | P22748 | 4/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1498066 | 0.93 | CA1 (0.36) | CA1CA4CA2CYP1A2CYP3A4 | |
| SCHEMBL6918110 | 0.90 | CA1 (0.35) | CA1CA4CA2CYP1A2CYP3A4 | |
| SCHEMBL6916836 | 0.90 | CA1 (0.35) | CA1CA4CA2CYP1A2CYP3A4 | |
| Zinc Ion SCHEMBL6916331 | 0.90 | CA1 (0.35) | CA1CA4CA2CYP1A2CYP3A4 | |
| SCHEMBL6916627 | 0.90 | CA1 (0.35) | CA1CA4CA2CYP1A2CYP3A4 | |
| SCHEMBL6909447 | 0.90 | CA1 (0.35) | CA1CA4CA2CYP1A2CYP3A4 | |
| SCHEMBL6917138 | 0.90 | CA1 (0.35) | CA1CA4CA2CYP1A2CYP3A4 | |
| SCHEMBL6909437 | 0.90 | CA1 (0.35) | CA1CA4CA2CYP1A2CYP3A4 | |
| SCHEMBL6913533 | 0.90 | CA1 (0.35) | CA1CA4CA2CYP1A2CYP3A4 | |
| SCHEMBL6916004 | 0.75 | CA1 (0.39) | CA1CA4CA2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110052650-A1 | POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST | Centre National De La Recherche Scientifique - CNR S (FR) | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110052650-A1 | POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST | MITF, SLCO2B1, SLCO2A1 | CA1 90/4885CA4 6/4885CA2 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.